Schwardt M, Debus J, Feick G, Hadaschik B, Hohenfellner M, Schuele R, Zacharias JP, Combs SE (2015)
Publication Type: Journal article
Publication year: 2015
Book Volume: 54
Pages Range: 1584-1590
Journal Issue: 11
DOI: 10.1007/s00120-014-3580-7
Multimodal treatment of prostate cancer is based on specific staging via imaging, clinical parameters, tumor markers and histopathological grading. Risk-adapted therapy encompasses wait and see, active surveillance, surgical intervention, radiotherapy and hormone therapy. Some patients also need a combination of these treatment options. Even though clinical parameters guide the treatment plan, patient wishes and preferences are incorporated. Against this background leading basic research scientists, urologists, radiotherapists, epidemiologists and members of other associated disciplines discussed state of the art treatment concepts, innovative trial designs and translational research projects at the international meeting „Challenges and Chances in Prostate Cancer Research“ organized by the German Cancer Aid (Deutsche Krebshilfe).
APA:
Schwardt, M., Debus, J., Feick, G., Hadaschik, B., Hohenfellner, M., Schuele, R.,... Combs, S.E. (2015). Interdisciplinary and individualized therapy of prostate cancer: International prostate cancer symposium Bonn 2013 – challenges and targets Interdisziplinäre und individualisierte Therapie des Prostatakarzinoms: Internationales Prostatakrebssymposium Bonn 2013 – Herausforderungen und Ziele. Urologe, 54(11), 1584-1590. https://dx.doi.org/10.1007/s00120-014-3580-7
MLA:
Schwardt, M., et al. "Interdisciplinary and individualized therapy of prostate cancer: International prostate cancer symposium Bonn 2013 – challenges and targets Interdisziplinäre und individualisierte Therapie des Prostatakarzinoms: Internationales Prostatakrebssymposium Bonn 2013 – Herausforderungen und Ziele." Urologe 54.11 (2015): 1584-1590.
BibTeX: Download